Oncology SE Management Flashcards
Breast Cancer Screening
- Begin yearly mammograms from 45-54 yo
- >= 55 yo, continue yearly or increase to Q2y
Cervical Cancer Screening
- 21-29 yo: Pap smear Q3y
- 30-65 yo: Pap smear + HPV DNA test Q5y
Colon Cancer Screening
- Stool-based tests - fecal occult blood test (gFOBT, Qy >= 45yo) or stool DNA test (Q3y)
- Visual exams of colon and rectum - colonoscopy Q10y and sigmoidoscopy Q5y
Lung Cancer Screening
- CT scan annually at 55-74 yo IF:
- In good health
- Have 30 pack-year smoking history
- Still smokes or quit within the past 15 years
Prostate Cancer Screening
IF patient chooses to be tests, involves:
- PSA test
- +/- DRE
Bleomycin Dose Limit
Lifetime Cumulative Dose of 400u
-Reason: pulmonary toxicity
Doxorubicin Dose Limit
Lifetime Cumulative Dose of 450-550 mg/m^2
-Reason: Cardiotoxicity
Cisplatin Dose Limit
Dose per cycle shouldn’t exceed 100 mg/m^2
-Reason: Nephrotoxicity
Vincristine Dose Limit
Single dose capped at 2 mg
-Reason: Neurotoxicity
Myelosuppression Agents/Tx
- All chemo EXCEPT Asparaginase, bleomycin, vincristine
- Neutropenia => CSF
- Anemia => RBC transfusions, ESAs in palliative ONLY
- Thrombocytopenia => platelet transfusions
N/V Agents/Tx
- Cisplatin, cyclophosphamide, ifosfamide
- Tx: Neurokinin-1 receptor antagonist (NK1-RA), 5HT3 antagonist, dexamethasone, IV/PO fluid hydration
Mucositis Agents/Tx
- Fluorouracil, MTX
- Tx: symptomatic; mucosal coating agents, topical anesthetics (2% viscous lidocaine), antifungals/virals (Nystatin susp. or clotrimazole troches)
Diarrhea Agents/Tx
- Irinotecan, capecitabine, fluorouracil, MTX
- Tx: IV/PO fluid hydration, antimotility meds (loperamide, max 16 mg/d)
- Irinotecan specific: atropine for early-onset (prevent or tx)
Constipation Agents/Tx
- Vincristine
- Tx: Stimulant laxatives, PEG 3350
Xerostomia Agents/Tx
- Radiation to head/neck
- Tx: Artificial saliva substitutes, pilocarpine
Cardiotoxicity Agents/Tx
- Cardiomyopathy: Anthracyclines
- QT Prolongation: Arsenic trioxide and many TKIs (ECG monitoring)
- Be sure not to exceed lifetime cumulative doses
- Give dexrazoxane prophylactically in doxorubicin pts
Pulmonary Toxicity Agents/Tx
- Fibrosis: Bleomycin, busulfan, carmustine, lomustine
- Pneumonitis: Immune therapy MAbs
- Don’t exceed lifetime cumulative dose of bleomycin
- Give steroids if autoimmune mechanism is suspected
Hepatotoxicity Agents/Tx
- Antiandrogens: bicalutamide, eflutamide, nilutamide
- Give steroids if autoimmune mechanism is suspected (immune therapy MAbs)
Nephrotoxicity Agents/Tx
- Cisplatin, MTX (high doses)
- Cisplatin specific: Amifostine (Ethyol) given prophylactically, don’t exceed dose limitation
- Ensure adequate hydration
Hemorrhagic Cystitis Agents/Tx
- Ifosfamide, cyclophosphamide (high doses)
- Mesna (Mesnex) - always given prophylactically with ifosfamide and sometimes with cyclophosphamide
- Ensure adequate hydration
Neuropathy Agents/Tx
- Peripheral: Vinca alkaloids, platinums, taxanes
- Vincristine limited to 2 mg/dose
- Avoid cold temperatures and beverages with oxiplatin
Thromboembolism Agents/Tx
- Aromatase inhibitors, SERMs
- Can cause stroke, DVT/PE, MI
- Consider thromboprophylaxis based on risk factors
Leucovorin
- Given with fluorouracil to enhance efficacy
- Given prophylactically after MTX to decrease myelosuppression and mucositis (high-dose therapy)
- Can also use levoleucovorin (Fusilev)
Vistogard
- Uridine Triacetate
- Antidote to Fluorouracil or capecitabine
- Use within 96 hours for an overdose to treat severe/life-threatening early-onset toxicity